China NT Pharma Group Company Limited (1011.HK)
HKD 0.27
(1.89%)
HKD 0.27
(1.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.36 Million | 207.09 Million | 226.69 Million | 221.73 Million | 365.96 Million | 571.52 Million |
| Cost of Revenue | - | 81.8 Million | 81.24 Million | 86.82 Million | 105.08 Million | 149.51 Million |
| Gross Profit | 7.36 Million | 125.28 Million | 145.45 Million | 134.9 Million | 260.88 Million | 422 Million |
| Operating Expenses | 7.36 Million | 117.55 Million | 228.39 Million | 217.82 Million | 254.8 Million | 361.48 Million |
| Selling, General and Administrative Expenses | 63.57 Million | 106.11 Million | 230.52 Million | 219.32 Million | 256.84 Million | 362.47 Million |
| Research and Development Expenses | - | 3.76 Million | 5.95 Million | 8.99 Million | 17.08 Million | 34.18 Million |
| Other Expenses | - | 11.43 Million | -2.13 Million | -1.5 Million | -2.03 Million | -302.16 Million |
| Cost and Expenses | 63.57 Million | 199.36 Million | 309.63 Million | 304.65 Million | 359.89 Million | 511 Million |
| Operating Income | - | 18.43 Million | -59.27 Million | -68.13 Million | -22.04 Million | -246.56 Million |
| Interest Expense | 28.81 Million | 71.73 Million | 88.72 Million | 85.11 Million | 103.04 Million | 80.35 Million |
| Income Tax Expense | 122 Thousand | 12.1 Million | 2.58 Million | -9.02 Million | 9.73 Million | 39.86 Million |
| Earnings before Tax | -33.36 Million | -54.29 Million | -148.75 Million | -200.28 Million | -583.47 Million | -561.99 Million |
| Net Income | -143.59 Million | -66.4 Million | -151.33 Million | -191.26 Million | -593.2 Million | -957.66 Million |
| Earnings Per Share Basic | -0.17 | -0.04 | -0.08 | -0.10 | -0.34 | -0.61 |
| Earnings Per Share Diluted | -0.73 | -0.04 | -0.08 | -0.10 | -0.34 | -0.61 |
| Weighted Average Shares Outstanding | 848.11 Million | 1.89 Billion | 1.88 Billion | 1.88 Billion | 1.76 Billion | 1.56 Billion |
| Weighted Average Shares Outstanding (Diluted) | 197.81 Million | 1.89 Billion | 1.88 Billion | 1.88 Billion | 1.76 Billion | 1.56 Billion |
| Gross Margin | 1.00 | 0.60 | 0.64 | 0.61 | 0.71 | 0.74 |
| EBIT Margin | -1.77 | 0.19 | -0.08 | -0.20 | 0.02 | -0.37 |
| Profit Margin | -19.49 | -0.32 | -0.67 | -0.86 | -1.62 | -1.68 |
| EBITDA | -13.01 Million | 10.39 Million | -17.77 Million | -43.73 Million | -155.97 Million | -210.91 Million |
| Earnings Before Tax Margin | - | 0.09 | -0.26 | -0.31 | -0.06 | -0.43 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 31.29 Million | 7.36 Million | 7.36 Million | 207.09 Million | 86.59 Million | 120.5 Million |
| Cost of Revenue | 25.59 Million | - | 30.3 Million | 81.8 Million | 36.17 Million | 45.63 Million |
| Gross Profit | 5.7 Million | 7.36 Million | -22.94 Million | 125.28 Million | 50.41 Million | 74.87 Million |
| Operating Expenses | 7.1 Million | 63.57 Million | 10.1 Million | 117.55 Million | 40.57 Million | 67.29 Million |
| Selling, General and Administrative Expenses | 7.1 Million | - | 10.1 Million | - | 31.28 Million | 75.08 Million |
| Research and Development Expenses | - | - | - | - | 3.76 Million | - |
| Other Expenses | - | 264 Thousand | - | 11.43 Million | - | - |
| Cost and Expenses | 32.69 Million | 63.57 Million | 10.1 Million | 199.36 Million | 76.75 Million | 112.92 Million |
| Operating Income | -1.39 Million | -56.2 Million | -2.74 Million | 18.43 Million | 19.15 Million | -236 Thousand |
| Interest Expense | - | 28.81 Million | - | 71.73 Million | - | - |
| Income Tax Expense | 124 Thousand | 122 Thousand | 816 Thousand | 12.1 Million | 11.16 Million | 949 Thousand |
| Earnings before Tax | 785 Thousand | -33.36 Million | -4.79 Million | -54.29 Million | -27 Million | -27.28 Million |
| Net Income | 661 Thousand | -143.59 Million | -5.61 Million | -66.4 Million | -38.16 Million | -28.23 Million |
| Earnings Per Share Basic | 0.00 | - | -0.00 | - | -0.02 | -0.01 |
| Earnings Per Share Diluted | 0.00 | - | -0.00 | - | -0.02 | -0.01 |
| Weighted Average Shares Outstanding | 1.97 Billion | 1.97 Billion | 1.93 Billion | 1.89 Billion | 1.9 Billion | 1.88 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.97 Billion | 1.97 Billion | 1.93 Billion | 1.89 Billion | 1.9 Billion | 1.88 Billion |
| Gross Margin | 0.18 | 1.00 | -3.11 | 0.60 | 0.58 | 0.62 |
| EBIT Margin | -0.04 | - | -0.35 | - | 0.31 | 0.08 |
| Profit Margin | 0.02 | -19.49 | -0.76 | -0.32 | -0.44 | -0.23 |
| EBITDA | -1.38 Million | - | -2.56 Million | - | 26.49 Million | 9.58 Million |
| Earnings Before Tax Margin | -0.04 | -7.63 | -0.37 | 0.09 | 0.22 | -0.00 |
KFAST-B
600562
ABSO
SDURF
PAY
8795